APO Research, Inc.

APO RESEARCH · REPORT

Immunoglobulin Products

Selected research

Industry Growth & Trends

Global Immunoglobulin Products Industry Growth and Trends Forecast to 2032

Market perspective

The global Immunoglobulin Products market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Immunoglobulin Products is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Immunoglobulin Products is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Immunoglobulin Products is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Immunoglobulin Products include Octapharma, Kedrion, Grifols, Emergent Biosolutions, CSL, China Biologic Products, Biotest Pharmaceuticals, Bio Products Laboratory and Bharat Serums and Vaccines, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Immunoglobulin Products market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Immunoglobulin Products market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Immunoglobulin Products market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Immunoglobulin Products.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Immunoglobulin Products market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Immunoglobulin Products Market by Company

Octapharma

Kedrion

Grifols

Emergent Biosolutions

CSL

China Biologic Products

Biotest Pharmaceuticals

Bio Products Laboratory

Bharat Serums and Vaccines

Immunoglobulin Products Segment by Type

IG A

IG D

IG E

IG G

IG M

Immunoglobulin Products Segment by Application

CIDP

Myasthenia Gravis

Congenital AIDS

ITP

Immunodeficiency Diseases

CLL

Multifocal Motor Neuropathy

Kawasaki Disease

Hypogammaglobulinemia

Immunoglobulin Products Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Immunoglobulin Products market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Immunoglobulin Products and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Immunoglobulin Products.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Immunoglobulin Products manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Immunoglobulin Products in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of IG A Table 2. Major Company of IG D Table 3. Major Company of IG E Table 4. Major Company of IG G Table 5. Major Company of IG M Table 6. Global Immunoglobulin Products Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Immunoglobulin Products Sales by Type (2021-2026) & (k units) Table 8. Global Immunoglobulin Products Sales Market Share in Volume by Type (2021-2026) Table 9. Global Immunoglobulin Products Sales by Type (2021-2026) & (US$ Million) Table 10. Global Immunoglobulin Products Sales Market Share in Value by Type (2021-2026) Table 11. Global Immunoglobulin Products Price by Type (2021-2026) & (US$/unit) Table 12. Global Immunoglobulin Products Sales by Type (2027-2032) & (k units) Table 13. Global Immunoglobulin Products Sales Market Share in Volume by Type (2027-2032) Table 14. Global Immunoglobulin Products Sales by Type (2027-2032) & (US$ Million) Table 15. Global Immunoglobulin Products Sales Market Share in Value by Type (2027-2032) Table 16. Global Immunoglobulin Products Price by Type (2027-2032) & (US$/unit) Table 17. North America Immunoglobulin Products Sales by Type (2021-2026) & (k units) Table 18. North America Immunoglobulin Products Sales by Type (2021-2026) & (US$ Million) Table 19. Europe Immunoglobulin Products Sales by Type (2021-2026) & (k units) Table 20. Europe Immunoglobulin Products Sales by Type (2021-2026) & (US$ Million) Table 21. Asia-Pacific Immunoglobulin Products Sales by Type (2021-2026) & (k units) Table 22. Asia-Pacific Immunoglobulin Products Sales by Type (2021-2026) & (US$ Million) Table 23. Latin America Immunoglobulin Products Sales by Type (2021-2026) & (k units) Table 24. Latin America Immunoglobulin Products Sales by Type (2021-2026) & (US$ Million) Table 25. Middle East and Africa Immunoglobulin Products Sales by Type (2021-2026) & (k units) Table 26. Middle East and Africa Immunoglobulin Products Sales by Type (2021-2026) & (US$ Million) Table 27. Immunoglobulin Products Industry Trends Table 28. Immunoglobulin Products Industry Drivers Table 29. Immunoglobulin Products Industry Opportunities and Challenges Table 30. Immunoglobulin Products Industry Restraints Table 31. Global Immunoglobulin Products Sales Revenue by Company (US$ Million) & (2021-2026) Table 32. Global Immunoglobulin Products Revenue Market Share by Company (2021-2026) Table 33. Global Immunoglobulin Products Sales by Company (2021-2026) & (k units) Table 34. Global Immunoglobulin Products Sales Share by Company (2021-2026) Table 35. Global Immunoglobulin Products Market Price by Company (2021-2026) & (US$/unit) Table 36. Global Immunoglobulin Products Industry Company Ranking, 2024 VS 2025 VS 2026 Table 37. Global Immunoglobulin Products Major Company Production Sites and Headquarters Table 38. Global Immunoglobulin Products Company, Product Type & Application Table 39. Global Immunoglobulin Products Company Establishment Date Table 40. Global Company Market Concentration Ratio (CR5 and HHI) Table 41. Global Immunoglobulin Products by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 42. Global Immunoglobulin Products Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 43. Global Immunoglobulin Products Sales by Region (2021-2026) & (k units) Table 44. Global Immunoglobulin Products Sales Market Share in Volume by Region (2021-2026) Table 45. Global Immunoglobulin Products Sales by Region (2021-2026) & (US$ Million) Table 46. Global Immunoglobulin Products Sales Market Share in Value by Region (2021-2026) Table 47. Global Immunoglobulin Products Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 48. Global Immunoglobulin Products Sales by Region (2027-2032) & (k units) Table 49. Global Immunoglobulin Products Sales Market Share in Volume by Region (2027-2032) Table 50. Global Immunoglobulin Products Sales by Region (2027-2032) & (US$ Million) Table 51. Global Immunoglobulin Products Sales Market Share in Value by Region (2027-2032) Table 52. Global Immunoglobulin Products Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 53. Global Immunoglobulin Products Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 54. Global Immunoglobulin Products Sales by Application (2021-2026) & (k units) Table 55. Global Immunoglobulin Products Sales Market Share in Volume by Application (2021-2026) Table 56. Global Immunoglobulin Products Sales by Application (2021-2026) & (US$ Million) Table 57. Global Immunoglobulin Products Sales Market Share in Value by Application (2021-2026) Table 58. Global Immunoglobulin Products Price by Application (2021-2026) & (US$/unit) Table 59. Global Immunoglobulin Products Sales by Application (2027-2032) & (k units) Table 60. Global Immunoglobulin Products Sales Market Share in Volume by Application (2027-2032) Table 61. Global Immunoglobulin Products Sales by Application (2027-2032) & (US$ Million) Table 62. Global Immunoglobulin Products Sales Market Share in Value by Application (2027-2032) Table 63. Global Immunoglobulin Products Price by Application (2027-2032) & (US$/unit) Table 64. North America Immunoglobulin Products Sales by Application (2021-2026) & (k units) Table 65. North America Immunoglobulin Products Sales by Application (2021-2026) & (US$ Million) Table 66. Europe Immunoglobulin Products Sales by Application (2021-2026) & (k units) Table 67. Europe Immunoglobulin Products Sales by Application (2021-2026) & (US$ Million) Table 68. Asia-Pacific Immunoglobulin Products Sales by Application (2021-2026) & (k units) Table 69. Asia-Pacific Immunoglobulin Products Sales by Application (2021-2026) & (US$ Million) Table 70. Latin America Immunoglobulin Products Sales by Application (2021-2026) & (k units) Table 71. Latin America Immunoglobulin Products Sales by Application (2021-2026) & (US$ Million) Table 72. Middle East and Africa Immunoglobulin Products Sales by Application (2021-2026) & (k units) Table 73. Middle East and Africa Immunoglobulin Products Sales by Application (2021-2026) & (US$ Million) Table 74. Octapharma Company Information Table 75. Octapharma Business Overview Table 76. Octapharma Immunoglobulin Products Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 77. Octapharma Immunoglobulin Products Product Portfolio Table 78. Octapharma Recent Development Table 79. Kedrion Company Information Table 80. Kedrion Business Overview Table 81. Kedrion Immunoglobulin Products Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 82. Kedrion Immunoglobulin Products Product Portfolio Table 83. Kedrion Recent Development Table 84. Grifols Company Information Table 85. Grifols Business Overview Table 86. Grifols Immunoglobulin Products Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 87. Grifols Immunoglobulin Products Product Portfolio Table 88. Grifols Recent Development Table 89. Emergent Biosolutions Company Information Table 90. Emergent Biosolutions Business Overview Table 91. Emergent Biosolutions Immunoglobulin Products Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 92. Emergent Biosolutions Immunoglobulin Products Product Portfolio Table 93. Emergent Biosolutions Recent Development Table 94. CSL Company Information Table 95. CSL Business Overview Table 96. CSL Immunoglobulin Products Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 97. CSL Immunoglobulin Products Product Portfolio Table 98. CSL Recent Development Table 99. China Biologic Products Company Information Table 100. China Biologic Products Business Overview Table 101. China Biologic Products Immunoglobulin Products Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 102. China Biologic Products Immunoglobulin Products Product Portfolio Table 103. China Biologic Products Recent Development Table 104. Biotest Pharmaceuticals Company Information Table 105. Biotest Pharmaceuticals Business Overview Table 106. Biotest Pharmaceuticals Immunoglobulin Products Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 107. Biotest Pharmaceuticals Immunoglobulin Products Product Portfolio Table 108. Biotest Pharmaceuticals Recent Development Table 109. Bio Products Laboratory Company Information Table 110. Bio Products Laboratory Business Overview Table 111. Bio Products Laboratory Immunoglobulin Products Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 112. Bio Products Laboratory Immunoglobulin Products Product Portfolio Table 113. Bio Products Laboratory Recent Development Table 114. Bharat Serums and Vaccines Company Information Table 115. Bharat Serums and Vaccines Business Overview Table 116. Bharat Serums and Vaccines Immunoglobulin Products Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 117. Bharat Serums and Vaccines Immunoglobulin Products Product Portfolio Table 118. Bharat Serums and Vaccines Recent Development Table 119. North America Immunoglobulin Products Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 120. North America Immunoglobulin Products Sales by Country (2021-2026) & (k units) Table 121. North America Immunoglobulin Products Sales Market Share by Country (2021-2026) Table 122. North America Immunoglobulin Products Sales Forecast by Country (2027-2032) & (k units) Table 123. North America Immunoglobulin Products Sales Market Share Forecast by Country (2027-2032) Table 124. North America Immunoglobulin Products Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 125. North America Immunoglobulin Products Market Size by Country (2021-2026) & (US$ Million) Table 126. North America Immunoglobulin Products Market Share by Country (2021-2026) Table 127. North America Immunoglobulin Products Market Size Forecast by Country (2027-2032) & (US$ Million) Table 128. North America Immunoglobulin Products Market Share Forecast by Country (2027-2032) Table 129. Europe Immunoglobulin Products Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 130. Europe Immunoglobulin Products Sales by Country (2021-2026) & (k units) Table 131. Europe Immunoglobulin Products Sales Market Share by Country (2021-2026) Table 132. Europe Immunoglobulin Products Sales Forecast by Country (2027-2032) & (k units) Table 133. Europe Immunoglobulin Products Sales Market Share Forecast by Country (2027-2032) Table 134. Europe Immunoglobulin Products Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 135. Europe Immunoglobulin Products Market Size by Country (2021-2026) & (US$ Million) Table 136. Europe Immunoglobulin Products Market Share by Country (2021-2026) Table 137. Europe Immunoglobulin Products Market Size Forecast by Country (2027-2032) & (US$ Million) Table 138. Europe Immunoglobulin Products Market Share Forecast by Country (2027-2032) Table 139. Asia-Pacific Immunoglobulin Products Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 140. Asia-Pacific Immunoglobulin Products Sales by Country (2021-2026) & (k units) Table 141. Asia-Pacific Immunoglobulin Products Sales Market Share by Country (2021-2026) Table 142. Asia-Pacific Immunoglobulin Products Sales Forecast by Country (2027-2032) & (k units) Table 143. Asia-Pacific Immunoglobulin Products Sales Market Share Forecast by Country (2027-2032) Table 144. Asia-Pacific Immunoglobulin Products Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 145. Asia-Pacific Immunoglobulin Products Market Size by Country (2021-2026) & (US$ Million) Table 146. Asia-Pacific Immunoglobulin Products Market Share by Country (2021-2026) Table 147. Asia-Pacific Immunoglobulin Products Market Size Forecast by Country (2027-2032) & (US$ Million) Table 148. Asia-Pacific Immunoglobulin Products Market Share Forecast by Country (2027-2032) Table 149. Latin America Immunoglobulin Products Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 150. Latin America Immunoglobulin Products Sales by Country (2021-2026) & (k units) Table 151. Latin America Immunoglobulin Products Sales Market Share by Country (2021-2026) Table 152. Latin America Immunoglobulin Products Sales Forecast by Country (2027-2032) & (k units) Table 153. Latin America Immunoglobulin Products Sales Market Share Forecast by Country (2027-2032) Table 154. Latin America Immunoglobulin Products Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 155. Latin America Immunoglobulin Products Market Size by Country (2021-2026) & (US$ Million) Table 156. Latin America Immunoglobulin Products Market Share by Country (2021-2026) Table 157. Latin America Immunoglobulin Products Market Size Forecast by Country (2027-2032) & (US$ Million) Table 158. Latin America Immunoglobulin Products Market Share Forecast by Country (2027-2032) Table 159. Middle East and Africa Immunoglobulin Products Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 160. Middle East and Africa Immunoglobulin Products Sales by Country (2021-2026) & (k units) Table 161. Middle East and Africa Immunoglobulin Products Sales Market Share by Country (2021-2026) Table 162. Middle East and Africa Immunoglobulin Products Sales Forecast by Country (2027-2032) & (k units) Table 163. Middle East and Africa Immunoglobulin Products Sales Market Share Forecast by Country (2027-2032) Table 164. Middle East and Africa Immunoglobulin Products Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 165. Middle East and Africa Immunoglobulin Products Market Size by Country (2021-2026) & (US$ Million) Table 166. Middle East and Africa Immunoglobulin Products Market Share by Country (2021-2026) Table 167. Middle East and Africa Immunoglobulin Products Market Size Forecast by Country (2027-2032) & (US$ Million) Table 168. Middle East and Africa Immunoglobulin Products Market Share Forecast by Country (2027-2032) Table 169. Key Raw Materials Table 170. Raw Materials Key Suppliers Table 171. Immunoglobulin Products Distributors List Table 172. Immunoglobulin Products Customers List Table 173. Research Programs/Design for This Report Table 174. Authors List of This Report Table 175. Secondary Sources Table 176. Primary Sources List of Figures Figure 1. Immunoglobulin Products Image Figure 2. Global Immunoglobulin Products Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Immunoglobulin Products Market Size (2021-2032) & (US$ Million) Figure 4. Global Immunoglobulin Products Sales (2021-2032) & (k units) Figure 5. IG A Image Figure 6. Global IG A Sales YoY Growth (2021-2032) & (k units) Figure 7. IG D Image Figure 8. Global IG D Sales YoY Growth (2021-2032) & (k units) Figure 9. IG E Image Figure 10. Global IG E Sales YoY Growth (2021-2032) & (k units) Figure 11. IG G Image Figure 12. Global IG G Sales YoY Growth (2021-2032) & (k units) Figure 13. IG M Image Figure 14. Global IG M Sales YoY Growth (2021-2032) & (k units) Figure 15. Global Immunoglobulin Products Market Size Overview by Type (2021-2032) & (US$ Million) Figure 16. Global Immunoglobulin Products Market Share by Type 2025 VS 2032 Figure 17. North America Immunoglobulin Products Sales Market Share in Volume by Type in 2025 Figure 18. North America Immunoglobulin Products Sales Market Share in Value by Type in 2025 Figure 19. Europe Immunoglobulin Products Sales Market Share in Volume by Type in 2025 Figure 20. Europe Immunoglobulin Products Sales Market Share in Value by Type in 2025 Figure 21. Asia-Pacific Immunoglobulin Products Sales Market Share in Volume by Type in 2025 Figure 22. Asia-Pacific Immunoglobulin Products Sales Market Share in Value by Type in 2025 Figure 23. Latin America Immunoglobulin Products Sales Market Share in Volume by Type in 2025 Figure 24. Latin America Immunoglobulin Products Sales Market Share in Value by Type in 2025 Figure 25. Middle East and Africa Immunoglobulin Products Sales Market Share in Volume by Type in 2025 Figure 26. Middle East and Africa Immunoglobulin Products Sales Market Share in Value by Type in 2025 Figure 27. Global Top 5 and 10 Immunoglobulin Products Players Market Share by Revenue in 2025 Figure 28. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. CIDP Image Figure 30. Global CIDP Sales YoY Growth (2021-2032) & (k units) Figure 31. Myasthenia Gravis Image Figure 32. Global Myasthenia Gravis Sales YoY Growth (2021-2032) & (k units) Figure 33. Congenital AIDS Image Figure 34. Global Congenital AIDS Sales YoY Growth (2021-2032) & (k units) Figure 35. ITP Image Figure 36. Global ITP Sales YoY Growth (2021-2032) & (k units) Figure 37. Immunodeficiency Diseases Image Figure 38. Global Immunodeficiency Diseases Sales YoY Growth (2021-2032) & (k units) Figure 39. CLL Image Figure 40. Global CLL Sales YoY Growth (2021-2032) & (k units) Figure 41. Multifocal Motor Neuropathy Image Figure 42. Global Multifocal Motor Neuropathy Sales YoY Growth (2021-2032) & (k units) Figure 43. Kawasaki Disease Image Figure 44. Global Kawasaki Disease Sales YoY Growth (2021-2032) & (k units) Figure 45. Hypogammaglobulinemia Image Figure 46. Global Hypogammaglobulinemia Sales YoY Growth (2021-2032) & (k units) Figure 47. Global Immunoglobulin Products Market Size Overview by Application (2021-2032) & (US$ Million) Figure 48. Global Immunoglobulin Products Market Share by Application 2025 VS 2032 Figure 49. North America Immunoglobulin Products Sales Market Share in Volume by Application in 2025 Figure 50. North America Immunoglobulin Products Sales Market Share in Value by Application in 2025 Figure 51. Europe Immunoglobulin Products Sales Market Share in Volume by Application in 2025 Figure 52. Europe Immunoglobulin Products Sales Market Share in Value by Application in 2025 Figure 53. Asia-Pacific Immunoglobulin Products Sales Market Share in Volume by Application in 2025 Figure 54. Asia-Pacific Immunoglobulin Products Sales Market Share in Value by Application in 2025 Figure 55. Latin America Immunoglobulin Products Sales Market Share in Volume by Application in 2025 Figure 56. Latin America Immunoglobulin Products Sales Market Share in Value by Application in 2025 Figure 57. Middle East and Africa Immunoglobulin Products Sales Market Share in Volume by Application in 2025 Figure 58. Middle East and Africa Immunoglobulin Products Sales Market Share in Value by Application in 2025 Figure 59. North America Immunoglobulin Products Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 60. North America Immunoglobulin Products Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. North America Immunoglobulin Products Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. North America Immunoglobulin Products Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Europe Immunoglobulin Products Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 64. Europe Immunoglobulin Products Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Europe Immunoglobulin Products Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Europe Immunoglobulin Products Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. Asia-Pacific Immunoglobulin Products Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 68. Asia-Pacific Immunoglobulin Products Sales Share by Country: 2021 VS 2025 VS 2032 Figure 69. Asia-Pacific Immunoglobulin Products Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 70. Asia-Pacific Immunoglobulin Products Market Share by Country: 2021 VS 2025 VS 2032 Figure 71. Latin America Immunoglobulin Products Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 72. Latin America Immunoglobulin Products Sales Share by Country: 2021 VS 2025 VS 2032 Figure 73. Latin America Immunoglobulin Products Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 74. Latin America Immunoglobulin Products Market Share by Country: 2021 VS 2025 VS 2032 Figure 75. Middle East and Africa Immunoglobulin Products Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 76. Middle East and Africa Immunoglobulin Products Sales Share by Country: 2021 VS 2025 VS 2032 Figure 77. Middle East and Africa Immunoglobulin Products Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 78. Middle East and Africa Immunoglobulin Products Market Share by Country: 2021 VS 2025 VS 2032 Figure 79. Immunoglobulin Products Value Chain Figure 80. Key Raw Materials Price Figure 81. Manufacturing Cost Structure Figure 82. Immunoglobulin Products Production Mode & Process Figure 83. Direct Comparison with Distribution Share Figure 84. Distributors Profiles Figure 85. Years Considered Figure 86. Research Process Figure 87. Key Executives Interviewed

Scope & coverage.

Types
  • IG A
  • IG D
  • IG E
  • IG G
  • IG M
Applications
  • CIDP
  • Myasthenia Gravis
  • Congenital AIDS
  • ITP
  • Immunodeficiency Diseases
  • CLL
  • Multifocal Motor Neuropathy
  • Kawasaki Disease
  • Hypogammaglobulinemia
Companies covered
  • Octapharma
  • Kedrion
  • Grifols
  • Emergent Biosolutions
  • CSL
  • China Biologic Products
  • Biotest Pharmaceuticals
  • Bio Products Laboratory
  • Bharat Serums and Vaccines

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Immunoglobulin Products Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Immunoglobulin Products Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Immunoglobulin Products Market by Type
  6. 1.3.1 IG A
  7. 1.3.2 IG D
  8. 1.3.3 IG E
  9. 1.3.4 IG G
  10. 1.3.5 IG M
  11. 1.4 Global Immunoglobulin Products Market Size by Type
  12. 1.4.1 Global Immunoglobulin Products Market Size Overview by Type (2021-2032)
  13. 1.4.2 Global Immunoglobulin Products Historic Market Size Review by Type (2021-2026)
  14. 1.4.3 Global Immunoglobulin Products Forecasted Market Size by Type (2027-2032)
  15. 1.5 Key Regions Market Size by Type
  16. 1.5.1 North America Immunoglobulin Products Sales Breakdown by Type (2021-2026)
  17. 1.5.2 Europe Immunoglobulin Products Sales Breakdown by Type (2021-2026)
  18. 1.5.3 Asia-Pacific Immunoglobulin Products Sales Breakdown by Type (2021-2026)
  19. 1.5.4 South America Immunoglobulin Products Sales Breakdown by Type (2021-2026)
  20. 1.5.5 Middle East and Africa Immunoglobulin Products Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Immunoglobulin Products Industry Trends
  2. 2.2 Immunoglobulin Products Industry Drivers
  3. 2.3 Immunoglobulin Products Industry Opportunities and Challenges
  4. 2.4 Immunoglobulin Products Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Immunoglobulin Products Revenue (2021-2026)
  2. 3.2 Global Top Players by Immunoglobulin Products Sales (2021-2026)
  3. 3.3 Global Top Players by Immunoglobulin Products Price (2021-2026)
  4. 3.4 Global Immunoglobulin Products Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Immunoglobulin Products Major Company Production Sites & Headquarters
  6. 3.6 Global Immunoglobulin Products Company, Product Type & Application
  7. 3.7 Global Immunoglobulin Products Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Immunoglobulin Products Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Immunoglobulin Products Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Immunoglobulin Products Tier 1, Tier 2, and Tier 3
4 Immunoglobulin Products Regional Status and Outlook
  1. 4.1 Global Immunoglobulin Products Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Immunoglobulin Products Historic Market Size by Region
  3. 4.2.1 Global Immunoglobulin Products Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Immunoglobulin Products Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Immunoglobulin Products Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Immunoglobulin Products Forecasted Market Size by Region
  7. 4.3.1 Global Immunoglobulin Products Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Immunoglobulin Products Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Immunoglobulin Products Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Immunoglobulin Products by Application
  1. 5.1 Immunoglobulin Products Market by Application
  2. 5.1.1 CIDP
  3. 5.1.2 Myasthenia Gravis
  4. 5.1.3 Congenital AIDS
  5. 5.1.4 ITP
  6. 5.1.5 Immunodeficiency Diseases
  7. 5.1.6 CLL
  8. 5.1.7 Multifocal Motor Neuropathy
  9. 5.1.8 Kawasaki Disease
  10. 5.1.9 Hypogammaglobulinemia
  11. 5.2 Global Immunoglobulin Products Market Size by Application
  12. 5.2.1 Global Immunoglobulin Products Market Size Overview by Application (2021-2032)
  13. 5.2.2 Global Immunoglobulin Products Historic Market Size Review by Application (2021-2026)
  14. 5.2.3 Global Immunoglobulin Products Forecasted Market Size by Application (2027-2032)
  15. 5.3 Key Regions Market Size by Application
  16. 5.3.1 North America Immunoglobulin Products Sales Breakdown by Application (2021-2026)
  17. 5.3.2 Europe Immunoglobulin Products Sales Breakdown by Application (2021-2026)
  18. 5.3.3 Asia-Pacific Immunoglobulin Products Sales Breakdown by Application (2021-2026)
  19. 5.3.4 South America Immunoglobulin Products Sales Breakdown by Application (2021-2026)
  20. 5.3.5 Middle East and Africa Immunoglobulin Products Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Octapharma
  2. 6.1.1 Octapharma Company Information
  3. 6.1.2 Octapharma Business Overview
  4. 6.1.3 Octapharma Immunoglobulin Products Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Octapharma Immunoglobulin Products Product Portfolio
  6. 6.1.5 Octapharma Recent Developments
  7. 6.2 Kedrion
  8. 6.2.1 Kedrion Company Information
  9. 6.2.2 Kedrion Business Overview
  10. 6.2.3 Kedrion Immunoglobulin Products Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Kedrion Immunoglobulin Products Product Portfolio
  12. 6.2.5 Kedrion Recent Developments
  13. 6.3 Grifols
  14. 6.3.1 Grifols Company Information
  15. 6.3.2 Grifols Business Overview
  16. 6.3.3 Grifols Immunoglobulin Products Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Grifols Immunoglobulin Products Product Portfolio
  18. 6.3.5 Grifols Recent Developments
  19. 6.4 Emergent Biosolutions
  20. 6.4.1 Emergent Biosolutions Company Information
  21. 6.4.2 Emergent Biosolutions Business Overview
  22. 6.4.3 Emergent Biosolutions Immunoglobulin Products Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Emergent Biosolutions Immunoglobulin Products Product Portfolio
  24. 6.4.5 Emergent Biosolutions Recent Developments
  25. 6.5 CSL
  26. 6.5.1 CSL Company Information
  27. 6.5.2 CSL Business Overview
  28. 6.5.3 CSL Immunoglobulin Products Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 CSL Immunoglobulin Products Product Portfolio
  30. 6.5.5 CSL Recent Developments
  31. 6.6 China Biologic Products
  32. 6.6.1 China Biologic Products Company Information
  33. 6.6.2 China Biologic Products Business Overview
  34. 6.6.3 China Biologic Products Immunoglobulin Products Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 China Biologic Products Immunoglobulin Products Product Portfolio
  36. 6.6.5 China Biologic Products Recent Developments
  37. 6.7 Biotest Pharmaceuticals
  38. 6.7.1 Biotest Pharmaceuticals Company Information
  39. 6.7.2 Biotest Pharmaceuticals Business Overview
  40. 6.7.3 Biotest Pharmaceuticals Immunoglobulin Products Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Biotest Pharmaceuticals Immunoglobulin Products Product Portfolio
  42. 6.7.5 Biotest Pharmaceuticals Recent Developments
  43. 6.8 Bio Products Laboratory
  44. 6.8.1 Bio Products Laboratory Company Information
  45. 6.8.2 Bio Products Laboratory Business Overview
  46. 6.8.3 Bio Products Laboratory Immunoglobulin Products Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Bio Products Laboratory Immunoglobulin Products Product Portfolio
  48. 6.8.5 Bio Products Laboratory Recent Developments
  49. 6.9 Bharat Serums and Vaccines
  50. 6.9.1 Bharat Serums and Vaccines Company Information
  51. 6.9.2 Bharat Serums and Vaccines Business Overview
  52. 6.9.3 Bharat Serums and Vaccines Immunoglobulin Products Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Bharat Serums and Vaccines Immunoglobulin Products Product Portfolio
  54. 6.9.5 Bharat Serums and Vaccines Recent Developments
7 North America by Country
  1. 7.1 North America Immunoglobulin Products Sales by Country
  2. 7.1.1 North America Immunoglobulin Products Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Immunoglobulin Products Sales by Country (2021-2026)
  4. 7.1.3 North America Immunoglobulin Products Sales Forecast by Country (2027-2032)
  5. 7.2 North America Immunoglobulin Products Market Size by Country
  6. 7.2.1 North America Immunoglobulin Products Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Immunoglobulin Products Market Size by Country (2021-2026)
  8. 7.2.3 North America Immunoglobulin Products Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Immunoglobulin Products Sales by Country
  2. 8.1.1 Europe Immunoglobulin Products Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Immunoglobulin Products Sales by Country (2021-2026)
  4. 8.1.3 Europe Immunoglobulin Products Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Immunoglobulin Products Market Size by Country
  6. 8.2.1 Europe Immunoglobulin Products Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Immunoglobulin Products Market Size by Country (2021-2026)
  8. 8.2.3 Europe Immunoglobulin Products Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Immunoglobulin Products Sales by Country
  2. 9.1.1 Asia-Pacific Immunoglobulin Products Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Immunoglobulin Products Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Immunoglobulin Products Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Immunoglobulin Products Market Size by Country
  6. 9.2.1 Asia-Pacific Immunoglobulin Products Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Immunoglobulin Products Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Immunoglobulin Products Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Immunoglobulin Products Sales by Country
  2. 10.1.1 South America Immunoglobulin Products Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Immunoglobulin Products Sales by Country (2021-2026)
  4. 10.1.3 South America Immunoglobulin Products Sales Forecast by Country (2027-2032)
  5. 10.2 South America Immunoglobulin Products Market Size by Country
  6. 10.2.1 South America Immunoglobulin Products Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Immunoglobulin Products Market Size by Country (2021-2026)
  8. 10.2.3 South America Immunoglobulin Products Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Immunoglobulin Products Sales by Country
  2. 11.1.1 Middle East and Africa Immunoglobulin Products Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Immunoglobulin Products Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Immunoglobulin Products Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Immunoglobulin Products Market Size by Country
  6. 11.2.1 Middle East and Africa Immunoglobulin Products Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Immunoglobulin Products Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Immunoglobulin Products Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Immunoglobulin Products Value Chain Analysis
  2. 12.1.1 Immunoglobulin Products Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Immunoglobulin Products Production Mode & Process
  7. 12.2 Immunoglobulin Products Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Immunoglobulin Products Distributors
  10. 12.2.3 Immunoglobulin Products Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.